• News
  • October 12, 2016
Mix of Rheumatoid & Osteo-arthritis is a Nightmarish Prospect

New Delhi, October 12: As you age, the degeneration in joints of your body is inevitable despite your best efforts to keep them well oiled. You cannot avert it. Sooner…

  • News
  • September 16, 2016
Too much dependence on your Smart Phone isn’t smart

Holding a cell phone to your ear for a long period of time increases activity in parts of the brain close to the antenna. Clearly there is an acute effect,…

  • News
  • September 16, 2016
Six Sigma Healthcare, India, Wins “Asia Hospital Management Award” 2016 at Vietnam

New Delhi: The Excellence is rarely found and more rarely valued. New Delhi, India based; Six Sigma Healthcare is awarded “Asia Biggest Honour” “ASIAN HOSPITAL MANAGEMENT AWARD 2016” at  Sheraton Hotel,…

  • News
  • September 16, 2016
Haseeb Pharma fluids test positive for bacterial presence

Hyderabad The Telangana Drug Control Authority lifted samples from 53 batches of the medical fluid supplied by Nagpur-based Haseeb Pharmaceuticals after doctors at Sarojini Devi Eye Hospital alleged contamination. Thirteen…

  • News
  • September 15, 2016
Cabinet approves redevelopment of residential colonies at West Ansari Nagar and Ayur Vigyan Nagar Campuses of AllMS

New Delhi (P.I.B.): The Union Cabinet under the Chairmanship of Prime Minister Narendra Modi has approved redevelopment of residential colonies at West Ansari Nagar and Ayur Vigyan Nagar Campuses of…

  • News
  • September 15, 2016
Himachal Pradesh A hub for spurious drugs

 Shimla With over 600 pharmaceutical industries, the state has become medicinal hub of India as it caters to around 40% domestic demand. But due to constantly failing the quality tests…

  • News
  • September 15, 2016
NPPA: Caping prices of drugs on Agenda

New Delhi More essential drugs are likely to come under price control with the government expected to decide on the matter in a meeting scheduled for next week. Out of…

  • News
  • September 15, 2016
Overcharging of price One-time settlement likely for pharma firms

New Delhi The drug price controller has formulated the draft of a “one-time settlement plan” for pharma-ceutical companies that admit to over-charging. According to the proposal, the department of pharmaceuticals…